---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-248077"
form_type: "8-K"
ticker: "WVE"
cik: "0001631574"
company_name: "Wave Life Sciences Ltd."
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:22:42.407772+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Wave Life Sciences updates corporate presentation on Oct 2, 2023; no specific details furnished

## Summary
- Company posted an updated corporate presentation on its investor website.
- Presentation covers general business updates and pipeline summary.
- No new financial data, clinical results, or guidance changes disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-23-248077
- form_type: 8-K
- ticker: WVE
- cik: 0001631574
- company_name: Wave Life Sciences Ltd.
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1631574/000119312523248077/0001193125-23-248077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1631574/000119312523248077/d503169d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-248077
- JSON: https://secwatch.observer/filing/0001193125-23-248077.json
- Plain text: https://secwatch.observer/filing/0001193125-23-248077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.